我国脑梗死药物临床试验评价标准的探讨

Discussion on the standardization for the clinical trials of drug therapy for cerebral infarction

目前国内药物治疗脑梗死临床试验中的一些标准尚无定论。本文讨论了临床试验中的脑梗死的分类、试验时的纳入标准、疗效指标、观察时间。提出试验时应充分考虑脑梗死发生后不同的病理及临床过程,进行合理的试验设计。

The standardization for the clinical trials of drug therapy for cerebral infarction has not yet determined in some aspects.In this paper,we discussed the classification of cerebral infarction,the eligibility,the evaluation of therapeutic effects and duration of followed up.The different pathologic and clinical process of cerebral infarction must be taken into consideration by the designers of clinical trials.